| 1 |
Łapczuk-Romańska J, Droździk M, Oswald S, Droździk M. Kidney Drug Transporters in Pharmacotherapy. Int J Mol Sci 2023;24. [PMID: 36769175 DOI: 10.3390/ijms24032856] [Reference Citation Analysis]
|
| 2 |
Qiu F, Dziegielewska KM, Huang Y, Habgood MD, Fitzpatrick G, Saunders NR. Developmental changes in the extent of drug binding to rat plasma proteins. Sci Rep 2023;13:1266. [PMID: 36690711 DOI: 10.1038/s41598-023-28434-1] [Reference Citation Analysis]
|
| 3 |
Puris E, Fricker G, Gynther M. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics 2023;15. [PMID: 36839686 DOI: 10.3390/pharmaceutics15020364] [Reference Citation Analysis]
|
| 4 |
Nies AT, Schaeffeler E, Schwab M. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 2022;238:108268. [DOI: 10.1016/j.pharmthera.2022.108268] [Reference Citation Analysis]
|
| 5 |
Fashe MM, Fallon JK, Miner TA, Tiley JB, Smith PC, Lee CR. Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. Front Pharmacol 2022;13:1004010. [DOI: 10.3389/fphar.2022.1004010] [Reference Citation Analysis]
|
| 6 |
Giacomini KM, Huang SM. More Than Pharmacokinetics: Transporters in Clinical Pharmacology. Clin Pharmacol Ther 2022;112:423-6. [PMID: 35989454 DOI: 10.1002/cpt.2710] [Reference Citation Analysis]
|
| 7 |
Wenzel C, Gödtke L, Reichstein A, Keiser M, Busch D, Drozdzik M, Oswald S. Gene Expression and Protein Abundance of Nuclear Receptors in Human Intestine and Liver: A New Application for Mass Spectrometry-Based Targeted Proteomics. Molecules 2022;27:4629. [DOI: 10.3390/molecules27144629] [Reference Citation Analysis]
|
| 8 |
Taggi V, Riera Romo M, Piquette-miller M, Meyer zu Schwabedissen HE, Neuhoff S. Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta. Pharmaceutics 2022;14:1376. [DOI: 10.3390/pharmaceutics14071376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Chu X, Prasad B, Neuhoff S, Yoshida K, Leeder JS, Mukherjee D, Taskar K, Varma MVS, Zhang X, Yang X, Galetin A. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Clin Pharmacol Ther 2022. [PMID: 35561140 DOI: 10.1002/cpt.2643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
